The Mount Sinai School of Medicine (MSSM) proposes to continue a highly successful Cancer Biology training program for predoctoral fellows and expand it to include postdoctoral fellows. This program reflects a major expansion of cancer research at MSSM, which has experienced 10-fold growth in NCI funding over the past 8 years. The training program reflects an integral component of the institution's Cancer Center, in which training mentors play key leadership roles. The program encompasses a laboratory-based, multidisciplinary program in cancer biology. Five predoctoral trainees would continue to be supported by the training program, which has demonstrated the ability to attract and develop a cadre of outstanding PhD and MD/PhD students in cancer focused research. The added postdoctoral training component would initially include 2 fellows and would be closely coordinated with an independent NCl Cancer Biology postdoctoral training grant, which emphasizes training of clinical fellows, expanding training through new, non-overlapping faculty members. The training faculty consists of 36 preceptors from 12 departments and centers throughout Mount Sinai. Of these faculty, 70% have peer-reviewed support from extramural agencies for cancer-related studies. The curriculum for the predoctoral and postdoctoral trainees involves some core elements including advanced course work in both basic and clinical cancer biology. All trainees will participate in regular conferences, which will utilize the superb clinical resources at Mount Sinai and will further expose trainees to clinical aspects of cancer. There will also be specific training elements for each group. The training program includes a rigorous evaluation and selection process for trainees, and the program is both cognizant of and actively involved in minority recruitment. This training program combines research in the biology of cancer with a curriculum that challenges trainees to consider how their research may be translated into improvements in the diagnosis and treatment of cancer. The trainees will work closely with faculty drawn from throughout Mount Sinai ensuring that this research is both comprehensive in scope and related to practical issues faced by physicians in preventing and treating cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA078207-09
Application #
7256894
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1999-07-20
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
9
Fiscal Year
2007
Total Cost
$377,072
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
D'Avola, Delia; Villacorta-Martin, Carlos; Martins-Filho, Sebastiao N et al. (2018) High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Sci Rep 8:11570
Sonoshita, Masahiro; Scopton, Alex P; Ung, Peter M U et al. (2018) A whole-animal platform to advance a clinical kinase inhibitor into new disease space. Nat Chem Biol 14:291-298
Labgaa, Ismail; Villacorta-Martin, Carlos; D'Avola, Delia et al. (2018) A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma. Oncogene 37:3740-3752
Bane, Octavia; Hectors, Stefanie J; Wagner, Mathilde et al. (2018) Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med 79:2564-2575
Pappas, Kyrie; Xu, Jia; Zairis, Sakellarios et al. (2017) p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes. Mol Cancer Res 15:1051-1062
Senturk, J C; Bohlman, S; Manfredi, J J (2017) Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53. Oncogene 36:6085-6096
Yadav, Rajesh K; Jablonowski, Carolyn M; Fernandez, Alfonso G et al. (2017) Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in S. pombe. Elife 6:
Kenny, T C; Hart, P; Ragazzi, M et al. (2017) Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis. Oncogene 36:4393-4404
Kenny, Timothy C; Germain, Doris (2017) mtDNA, Metastasis, and the Mitochondrial Unfolded Protein Response (UPRmt). Front Cell Dev Biol 5:37
Chernyavskaya, Yelena; Mudbhary, Raksha; Zhang, Chi et al. (2017) Loss of DNA methylation in zebrafish embryos activates retrotransposons to trigger antiviral signaling. Development 144:2925-2939

Showing the most recent 10 out of 96 publications